Withdrawal of parenteral phenobarbitone--implications for resource-poor countries. by Wilmshurst, J, van Toorn, R, Newton, C

Tuberculous meningitis: more questions, still too few answers. by Thwaites, G, van Toorn, R, Schoeman, J

Reply to Baxter by Marais, BJ, Van Toorn, R, Figaji, T, Thwaites, GE, Tuberculous Meningitis International Research Consortium

Management of intracranial tuberculous mass lesions: How long should we treat for? by Marais, S, Van Toorn, R, Chow, FC, Manesh, A, Siddiqi, OK, Figaji, A, Schoeman, JF, Meintjes, G, Donovan, J, Hamers, RL, Thuong, NTT

Standardized methods for enhanced quality and comparability of tuberculous meningitis studies by Marais, B, Heemskerk, A, Marais, S, van Crevel, R, Rohlwink, U, Caws, M, Meintjes, G, Misra, U, Mai, N, Ruslami, R, Seddon, J, Solomons, R, van Toorn, R, Figaji, A, McIlleron, H, Aarnoutse, R, Schoeman, J, Wilkinson, R, Thwaites, G